Leidos Biomedical Research Inc.
Federal Contractor · Rank #116
Leidos Biomedical Research Inc. Federal Spending Profile
Leidos Biomedical Research Inc. is a mid-sized federal recipient, with $869.3M in total federal obligations spread across 25 awards reported on USAspending.gov. That places Leidos Biomedical Research Inc. #116 among federal contractors ranked by total obligations.
Every one of Leidos Biomedical Research Inc.'s 25 federal awards is a procurement contract rather than a grant — the company sells goods or services to the government rather than receiving grant funding.
Leidos Biomedical Research Inc.'s federal work runs through a single agency relationship: Department of Health and Human Services. With no other agency customers in the record, the company's federal revenue rises or falls with that one relationship.
What the federal government buys from Leidos Biomedical Research Inc. is led by Other Services ($9.0B), followed by IT & Software ($363.3M); together these categories describe the goods and services the company is paid to deliver.
Its largest single recent award is a $4.8B contract from the Department of Health and Human Services, described in the federal record as "Tas::75 0849::Tas Oper Of Govt R&D Goco Facilities."
Track Leidos Biomedical Research Inc.
Subscribe for TaxDollarData updates by email. No spam, unsubscribe anytime.
Spending by Agency
Recent Awards
| Description | Agency | Start Date | Amount |
|---|---|---|---|
| TAS::75 0849::TAS OPER OF GOVT R&D GOCO FACILITIES | Department of Health and Human Services | Sep 26, 2008 | $4.8B |
| NCI OPERATIONAL TASK ORDER | Department of Health and Human Services | Aug 31, 2020 | $1.8B |
| NCI OPERATIONAL TASK ORDER | Department of Health and Human Services | Aug 31, 2019 | $432.4M |
| NCI FY25 OPERATIONAL TASK ORDER | Department of Health and Human Services | Sep 28, 2024 | $398.9M |
| NIAID DCR OPERATIONAL TASK ORDER COVID FUNDING IN THE AMOUNT OF $3,706,224 FOR COVID RELATED EFFORTS ON THIS TASK ORDER | Department of Health and Human Services | Aug 31, 2020 | $291.2M |
| NIAID COVID-19 ACTIV3 | Department of Health and Human Services | Sep 2, 2020 | $233.6M |
| THE OBJECTIVE OF THIS TASK ORDER SUPPORTS NIAIDS GOAL TO CONDUCT A SERIES OF STANDARDIZED PHASE 1 AND PHASE 2 TRIALS ON NEXT-GENERATION VACCINES TO GENERATE DATA TO INFORM DECISIONS ON WHICH CANDIDATES TO SUPPORT FOR ADVANCED DEVELOPMENT. | Department of Health and Human Services | Jun 1, 2023 | $173.3M |
| MD NET | Department of Health and Human Services | Sep 26, 2019 | $163.5M |
| CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET) | Department of Health and Human Services | Feb 10, 2021 | $143.6M |
| ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2) | Department of Health and Human Services | Feb 16, 2021 | $141.7M |
| FFRDC SPACE MANAGEMENT TASK ORDER (LEASES) | Department of Health and Human Services | Aug 30, 2019 | $126.4M |
| NIAID VRC | Department of Health and Human Services | Aug 31, 2020 | $121.5M |
| DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT, OVERSIGHT, EXECUTION, CLOSEOUT AND PUBLICATION OF FINDINGS OF A PROSPECTIVE OBSERVATIONAL STUDY OF ADULT AND PEDIATRIC PATIENTS WITH UNKNOWN FEBRILE ILLNESS FR | Department of Health and Human Services | Sep 28, 2020 | $97.5M |
| ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II: I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF THE SAFETY AND EFFICACY OF INVESTIGATIONAL THERAPEUTICS FOR THE TREATMENT OF COVID-19 (2,000 SUBJECTS | Department of Health and Human Services | Apr 1, 2020 | $89.6M |
| ENABLING NCI CLINICAL & RESEARCH DATA SHARING | Department of Health and Human Services | Aug 31, 2021 | $80.9M |
| HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXPAND DATA COMMONS; 09/14/18-09/13/23 | Department of Health and Human Services | Sep 11, 2018 | $67.0M |
| NIAID DCR OPERATIONAL TASK ORDER | Department of Health and Human Services | Aug 31, 2024 | $65.3M |
| DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS | Department of Health and Human Services | Sep 28, 2020 | $56.5M |
| EBOLA VIRUS AND OTHER INFECTIOUS DISEASES | Department of Health and Human Services | Sep 30, 2018 | $56.4M |
| CELL-BASED IMMUNOTHERAPY PRODUCTS | Department of Health and Human Services | Sep 24, 2018 | $53.5M |
All federal spending data sourced from USAspending.gov, the official source for federal award data as mandated by the Government Accountability Office.
Leidos Biomedical Research Inc. Federal Contracts FAQ
Leidos Biomedical Research Inc. has received $869,311,933 in total federal obligations across 25 awards and 25 contracts.
Leidos Biomedical Research Inc. works with 1 federal agencies, including Department of Health and Human Services. The largest agency relationships are based on total dollar obligations.
Leidos Biomedical Research Inc. has received federal awards in multiple states.
Leidos Biomedical Research Inc. is ranked #116 among the largest federal contractors by total obligation amount. Rankings are based on USASpending.gov data for FY2024.
Explore Other Federal Contractors
Spending figures represent total federal obligations for FY2024, as reported through USASpending.gov. Rankings are based on aggregate obligation amounts across all contract, grant, and direct payment awards.